Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 1, 2008, Pages 260-266

  Gu, Yang ^a   Lewis, David F ^a   Wang, Yuping ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; PLACENTAL GROWTH FACTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; OXYGEN CONCENTRATION; PATHOPHYSIOLOGY; PLACENTA FUNCTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN SYNTHESIS; SOLUBILITY; TROPHOBLAST; WESTERN BLOTTING;

EID: 38149017731     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1550     Document Type: Article

References (23)

1. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA 2004 Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683
2. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group 2006 Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med [Erratum (2006) 355:1840] 355:992-1005
3. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA 2003 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658
4. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA 2006 Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12:642-649
5. Park JE, Chen HH, Winer J, Houck KA, Ferrara N 1994 Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269:25646-25654
6. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M 2005 A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 96:684-692
7. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, De Mol M, Bono F, Kliche S, Fellbrich G, Ballmer-Hofer K, Maglione D, Mayr-Beyrle U, Dewerchin M, Dombrowski S, Stanimirovic D, Van Hummelen P, Dehio C, Hicklin DJ, Persico G, Herbert JM, Communi D, Shibuya M, Collen D, Conway EM, Carmeliet P 2003 Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9:936-943
8. Nagy JA, Dvorak AM, Dvorak HF 2003 VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med 13:169-175
9. National Institutes of Health, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program 2000 Working group report on high blood pressure in pregnancy. National Institutes of Health. National Heart, Lung, and Blood Institute. National High Blood Pressure Education Program. NIH Publication no. 00-3029. Bethesda, MD: National Institutes of Health
10. Wang Y, Walsh SW 2001 Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in preeclampsia. Placenta 22:206-212
11. Li H, Gu B, Zhang Y, Lewis DF, Wang Y 2005 Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 25:210-217
12. Bowen RS, Zhang Y, Gu Y, Lewis DF, Wang Y 2005 Increased phospholipase A2and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition. Placenta 26:402-409
13. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW AA 2007 Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115:1789-1797
14. Wang Y, Walsh SW 1996 Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig 3:179-184
15. Walsh SW, Wang Y 1995 Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 80:1888-1893
16. Walsh SW, Behr MJ, Allen NH 1985 Placental prostacyclin production in normal and toxemic pregnancies. Am J Obstet Gynecol 151:110-115
17. Rajakumar A, Doty K, Daftary A, Harger G, Conrad KP 2003 Impaired oxygen-dependent reduction of HIF-1α and -2α proteins in pre-eclamptic placentae. Placenta [Erratum (2003) 24:711] 24:199-208
18. Gougos A, Letarte M 1990 Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265:8361-8364
19. Raab U, Velasco B, Lastres P, Letamendia A, Cales C, Langa C, Tapia E, Lopez-Bote JP, Paez E, Bernabeu C 1999 Expression of normal and truncated forms of human endoglin. Biochem J 339:579-588
20. Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G, Marme D, Martiny-Baron G 1997 Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J Biol Chem 272:10382-10388
21. Lis H, Sharon N 1993 Protein glycosylation. Structural and functional aspects. Eur J Biochem 218:1-27
22. Ji I, Ji TH 1990 Differential interactions of human choriogonadotropin and its antagonistic aglycosylated analog with their receptor. Proc Natl Acad Sci USA 87:4396-4400
23. Kendall RL, Thomas KA 1993 Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90:10705-10709